Avant Diagnostics, Inc Total Liabilities and Equity
Avant Diagnostics, Inc had Total Liabilities and Equity of $4.91 million as of 2018-12-31, per its 10-Q filed 2019-03-13.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2019-03-13
- 2018-12-31: Liabilities and Equity $4.91M.
- 2018-09-30: Liabilities and Equity $4.82M.
- 2018-06-30: Liabilities and Equity $5.15M.
- 2018-03-31: Liabilities and Equity $5.03M.
| Period end | Liabilities and Equity |
|---|---|
| 2018-12-31 | $4.91M 10-Q · filed 2019-03-13 |
| 2018-09-30 | $4.82M 10-Q · filed 2019-03-13 |
| 2018-06-30 | $5.15M 10-Q · filed 2019-01-30 |
| 2018-03-31 | $5.03M 10-Q · filed 2019-01-09 |
| 2017-12-31 | $5.15M 10-Q · filed 2018-12-28 |
| 2017-09-30 | $5.23M 10-K · filed 2019-03-01 |
| 2017-06-30 | $5.63M 10-Q · filed 2018-12-04 |
| 2017-03-31 | $5.70M 10-Q · filed 2018-10-23 |
| 2016-12-31 | $6.01M 10-Q · filed 2018-10-23 |
| 2016-09-30 | $5.68M 10-Q · filed 2018-12-04 |
| 2016-06-30 | $5.97M 10-Q · filed 2017-09-26 |
| 2016-03-31 | $2.07M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $1.92M 10-Q · filed 2016-02-16 |
| 2015-09-30 | $1.84M 10-K · filed 2018-08-28 |
| 2015-06-30 | $1.89M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $2.82M 10-Q · filed 2015-07-22 |
| 2014-12-31 | $2.96M 10-Q · filed 2015-04-07 |
| 2014-10-31 | $0.00 10-K · filed 2015-02-12 |
| 2014-09-30 | $3.30M 10-K · filed 2016-01-13 |
| 2014-07-31 | $0.00 10-Q · filed 2014-09-19 |
| 2014-04-30 | $0.00 10-Q · filed 2014-06-23 |
| 2014-01-31 | $0.00 10-Q · filed 2014-03-24 |
| 2013-10-31 | $0.00 10-K · filed 2015-02-12 |
| 2013-07-31 | $12.20K 10-Q · filed 2013-09-23 |
| 2013-04-30 | $100.90K 10-Q · filed 2013-06-14 |
| 2013-01-31 | $211.56K 10-Q · filed 2013-03-20 |
| 2012-10-31 | $295.80K 10-K · filed 2014-02-12 |
| 2012-07-31 | $1.85M 10-Q/A · filed 2012-12-18 |
| 2012-04-30 | $1.81M 10-Q · filed 2012-06-14 |
| 2012-01-31 | $1.49M 10-Q · filed 2012-03-16 |
| 2011-10-31 | $1.52M 10-K · filed 2013-02-14 |
| 2011-07-31 | $1.48M 10-Q/A · filed 2012-01-19 |
| 2010-10-31 | $658.46K 10-K · filed 2012-02-14 |